83 related articles for article (PubMed ID: 8486402)
1. Reduction of the cost of testing for antibody to human immunodeficiency virus, without losing sensitivity, by pooling sera.
Babu PG; Saraswathi NK; Vaidyanathan H; John TJ
Indian J Med Res; 1993 Jan; 97():1-3. PubMed ID: 8486402
[TBL] [Abstract][Full Text] [Related]
2. Pooling of sera for human immunodeficiency virus (HIV) testing: an economical method for use in developing countries.
Emmanuel JC; Bassett MT; Smith HJ; Jacobs JA
J Clin Pathol; 1988 May; 41(5):582-5. PubMed ID: 3164325
[TBL] [Abstract][Full Text] [Related]
3. Reducing the cost of HIV antibody testing.
Tamashiro H; Maskill W; Emmanuel J; Fauquex A; Sato P; Heymann D
Lancet; 1993 Jul; 342(8863):87-90. PubMed ID: 8100916
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of efficacy of pooled sera in a human immunodeficiency virus antibody prevalence in population surveys.
Pătraşcu IV
Rev Roum Virol; 1990; 41(1):45-51. PubMed ID: 2223657
[TBL] [Abstract][Full Text] [Related]
5. Relevance of antibody content and test format in HIV testing of pooled sera.
Monzon OT; Paladin FJ; Dimaandal E; Balis AM; Samson C; Mitchell S
AIDS; 1992 Jan; 6(1):43-8. PubMed ID: 1543565
[TBL] [Abstract][Full Text] [Related]
6. Site-directed enzyme-linked immunosorbent assay with a synthetic simian immunodeficiency virus SIVmac peptide identifying antibodies against the HIV-2 transmembrane glycoprotein.
Norrby E; Chiodi F; Whalley A; Parks E; Nauclér A; Costa CM; Torstensson R; Biberfeld G
AIDS; 1989 Jan; 3(1):17-20. PubMed ID: 2469436
[TBL] [Abstract][Full Text] [Related]
7. Use of seroconversion panels to estimate delay in detection of anti-human immunodeficiency virus antibodies by enzyme-linked immunosorbent assay of pooled compared to singleton serum samples.
Novack L; Galai N; Yaari A; Orgel M; Shinar E; Sarov B
J Clin Microbiol; 2006 Aug; 44(8):2909-13. PubMed ID: 16891511
[TBL] [Abstract][Full Text] [Related]
8. Feasibility of pooled-sample testing for the detection of porcine reproductive and respiratory syndrome virus antibodies on serum samples by ELISA.
Rovira A; Cano JP; Muñoz-Zanzi C
Vet Microbiol; 2008 Jul; 130(1-2):60-8. PubMed ID: 18243590
[TBL] [Abstract][Full Text] [Related]
9. Rapid HIV versus enzyme-linked immunosorbent assay screening in a low-risk Mexican American population presenting in labor: a cost-effectiveness analysis.
Doyle NM; Levison JE; Gardner MO
Am J Obstet Gynecol; 2005 Sep; 193(3 Pt 2):1280-5. PubMed ID: 16157152
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of human immunodeficiency virus seroprevalence in population surveys using pooled sera.
Kline RL; Brothers TA; Brookmeyer R; Zeger S; Quinn TC
J Clin Microbiol; 1989 Jul; 27(7):1449-52. PubMed ID: 2768435
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the indirect immunofluorescence assay with western blot for the detection of HIV antibody.
Abraham P; Babu PG; John TJ
Indian J Med Res; 1994 Apr; 99():143-8. PubMed ID: 7927564
[TBL] [Abstract][Full Text] [Related]
12. Strategies for laboratory HIV testing: an examination of alternative approaches not requiring Western blot.
Sato PA; Maskill WJ; Tamashiro H; Heymann DL
Bull World Health Organ; 1994; 72(1):129-34. PubMed ID: 8131248
[TBL] [Abstract][Full Text] [Related]
13. Sensitivity and specificity of pooled versus individual sera in a human immunodeficiency virus antibody prevalence study.
Cahoon-Young B; Chandler A; Livermore T; Gaudino J; Benjamin R
J Clin Microbiol; 1989 Aug; 27(8):1893-5. PubMed ID: 2504779
[TBL] [Abstract][Full Text] [Related]
14. Utilization of used human immunodeficiency virus ELISA microplates & surplus reagents for HIV antibody testing.
Makhija SK; Dhanvijay AG; Pathak AA; Saoji AM
Indian J Med Res; 1995 Oct; 102():159-61. PubMed ID: 8543359
[TBL] [Abstract][Full Text] [Related]
15. Feasibility of pooling sera for HIV-1 viral RNA to diagnose acute primary HIV-1 infection and estimate HIV incidence.
Quinn TC; Brookmeyer R; Kline R; Shepherd M; Paranjape R; Mehendale S; Gadkari DA; Bollinger R
AIDS; 2000 Dec; 14(17):2751-7. PubMed ID: 11125894
[TBL] [Abstract][Full Text] [Related]
16. Successful use of pooled sera to determine HIV-1 seroprevalence in Zaire with development of cost-efficiency models.
Behets F; Bertozzi S; Kasali M; Kashamuka M; Atikala L; Brown C; Ryder RW; Quinn TC
AIDS; 1990 Aug; 4(8):737-41. PubMed ID: 2124494
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the World Health Organisation antibody-testing strategy for the individual patient diagnosis of HIV infection (strategy III).
Martin DJ; Blackburn NK; O'Connell KF; Brant ET; Goetsch EA
S Afr Med J; 1995 Sep; 85(9):877-80. PubMed ID: 8545748
[TBL] [Abstract][Full Text] [Related]
18. Comparative evaluation of 36 commercial assays for detecting antibodies to HIV.
Van Kerckhoven I; Vercauteren G; Piot P; van der Groen G
Bull World Health Organ; 1991; 69(6):753-60. PubMed ID: 1786625
[TBL] [Abstract][Full Text] [Related]
19. Measurement of HIV-1 p24 antigen by signal-amplification-boosted ELISA of heat-denatured plasma is a simple and inexpensive alternative to tests for viral RNA.
Schüpbach J
AIDS Rev; 2002; 4(2):83-92. PubMed ID: 12152521
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of HIV serial and parallel serologic testing algorithms in Abidjan, Côte d'Ivoire.
Nkengasong JN; Maurice C; Koblavi S; Kalou M; Yavo D; Maran M; Bile C; N'guessan K; Kouadio J; Bony S; Wiktor SZ; Greenberg AE
AIDS; 1999 Jan; 13(1):109-17. PubMed ID: 10207552
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]